LAST NEWS
6 April 2020
Extraordinary Shareholders’ Meeting of April 6, 2020
Quorum not reached Second call of the Extraordinary Shareholders' meeting on 27 April, 2020 Read the press release (in French)
1 April 2020
Extraordinary Shareholders’ Meeting of April 6, 2020 behind closed doors
In the context of the Covid-19 epidemic and in accordance with the measures taken by the government to stop the virus proliferation, the Board of Directors has decided to hold the general…
18 March 2020
Invitation to the Extraordinary Shareholders’ Meeting of April 6, 2020
Availability of preparatory documents for the Annual General Meeting and remote participation details. Read the press release (in French)
6 March 2020
Number of shares and voting rights as at 29/02/2020
Europlasma declares the number of voting rights and shares comprising its share capital as at 29th Frebruary. Read the press release (in French)
28 February 2020
Consolidation of shares planned and equity financing secured
Extraordinary General Meeting convened on April 6, 2020 Plan to reduce share capital by charging losses Plan to consolidate of shares Authorization to finance future projects Confirmation…
5 February 2020
Number of shares and voting rights as at 31/01/2020
Europlasma declares the number of voting rights and shares comprising its share capital as at 31st January. Read the press release (in French)
10 January 2020
Number of shares and voting rights as at 31/12/2019
Europlasma declares the number of voting rights and shares comprising its share capital as at 31st December. Read the press release (in French)
7 January 2020
Ordinary General Meeting of Shareholders holds on 20 Dec. 2019
All resolutions proposed to the General Meeting of Shareholders on 20 December 2019 have been approuved. See all documents regarding the OGM (in French)
5 December 2019
Number of shares and voting rights as at 30/11/2019
Europlasma declares the number of voting rights and shares comprising its share capital as at 30th November. Read the press release (in French)